BR112022015112A2 - Composição farmacêutica adequada para liberação vaginal e uso da mesma - Google Patents
Composição farmacêutica adequada para liberação vaginal e uso da mesmaInfo
- Publication number
- BR112022015112A2 BR112022015112A2 BR112022015112A BR112022015112A BR112022015112A2 BR 112022015112 A2 BR112022015112 A2 BR 112022015112A2 BR 112022015112 A BR112022015112 A BR 112022015112A BR 112022015112 A BR112022015112 A BR 112022015112A BR 112022015112 A2 BR112022015112 A2 BR 112022015112A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- combination
- vaginal
- suitable pharmaceutical
- release
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- ZCJYUTQZBAIHBS-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C=CC(SC=2C=CC=CC=2)=CC=1)CN1C=NC=C1 ZCJYUTQZBAIHBS-UHFFFAOYSA-N 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229960001274 fenticonazole Drugs 0.000 abstract 2
- 208000034423 Delivery Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 229960005015 local anesthetics Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009677 vaginal delivery Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR202001511 | 2020-01-31 | ||
| PCT/TR2021/050086 WO2021154188A1 (en) | 2020-01-31 | 2021-01-29 | Pharmaceutical composition suitable for vaginal delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022015112A2 true BR112022015112A2 (pt) | 2022-09-27 |
Family
ID=77079220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022015112A BR112022015112A2 (pt) | 2020-01-31 | 2021-01-29 | Composição farmacêutica adequada para liberação vaginal e uso da mesma |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4096655A4 (es) |
| BR (1) | BR112022015112A2 (es) |
| EC (1) | ECSP22067445A (es) |
| MX (1) | MX2022009303A (es) |
| WO (1) | WO2021154188A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0405406D0 (en) * | 2004-03-10 | 2004-04-21 | Edko Pazarlama Tanitim Ltd Sti | Anti-vaginitis compositions |
| US20060137684A1 (en) * | 2004-12-01 | 2006-06-29 | Celeste Evans | Compositions and methods of treating irritation and kit therefor |
| CN103690476A (zh) * | 2014-01-06 | 2014-04-02 | 海南海力制药有限公司 | 微粉化硝酸芬替康唑制剂组合物及其制备方法 |
| TR201413590A3 (en) * | 2014-11-17 | 2021-06-21 | Pharmaceutical composition for use in treatment of vaginal infection comprises active substance or its derivative exhibiting antiprotozoal activity, and local anesthetic agent | |
| US20170165233A1 (en) * | 2014-12-20 | 2017-06-15 | John Malcolm Hall Gregg | Antimicrobial drug synthesis and therapeutic compositions |
| RU2674765C2 (ru) * | 2016-10-03 | 2018-12-13 | Михаил Лукич Ткаченко | Антигрибковая композиция эвтектического типа (варианты) |
| CN108079098A (zh) * | 2018-02-28 | 2018-05-29 | 翔宇药业股份有限公司 | 抗真菌感染的药物制剂及其制作方法 |
| CN108210448A (zh) * | 2018-04-09 | 2018-06-29 | 翔宇药业股份有限公司 | 硝酸芬替康唑栓剂及其应用 |
-
2021
- 2021-01-29 BR BR112022015112A patent/BR112022015112A2/pt unknown
- 2021-01-29 WO PCT/TR2021/050086 patent/WO2021154188A1/en unknown
- 2021-01-29 MX MX2022009303A patent/MX2022009303A/es unknown
- 2021-01-29 EP EP21748063.1A patent/EP4096655A4/en active Pending
-
2022
- 2022-08-26 EC ECSENADI202267445A patent/ECSP22067445A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4096655A4 (en) | 2024-02-28 |
| ECSP22067445A (es) | 2022-11-30 |
| EP4096655A1 (en) | 2022-12-07 |
| WO2021154188A1 (en) | 2021-08-05 |
| MX2022009303A (es) | 2022-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10085995B2 (en) | Topical compositions and methods of treatment of anorectal disorders | |
| CA2646667C (en) | Methods of treating hot flashes with formulations for transdermal or transmucosal application | |
| Olszewski | Episodic dermatolymphangioadenitis (DLA) in patients with lymphedema of the lower extremities before and after administration of benzathine penicillin: a preliminary study | |
| BRPI0512311A (pt) | uso de meloxicam em medicina veterinária para o tratamento de doenças inflamatórias dolorosas | |
| CO2021000174A2 (es) | Composiciones tópicas para el alivio del dolor | |
| BRPI0510449A (pt) | uso de formulações de meloxicam em medicina veterinária | |
| US9173972B2 (en) | Methods and compositions for promoting wound healing | |
| BR112017016087A2 (pt) | formulações para coxim articular adiposo e métodos de uso das mesmas | |
| CO6220945A2 (es) | Uso de una composicion que comprende formoterol y dipropianato de beclometasona para la prevencion y/o tratamiento de una exacerbacion de asma | |
| BRPI0607172A2 (pt) | método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos | |
| BR112022015112A2 (pt) | Composição farmacêutica adequada para liberação vaginal e uso da mesma | |
| BRPI0413474A (pt) | uso de interferon e ribavirina e kit para uso no tratamento de infecções virais | |
| BRPI0415651A (pt) | métodos para tratar, prevenir, modificar e/ou administrar fibromialgia, e para reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de fibromialgia, e, composição farmacêutica | |
| Valadares et al. | Genitourinary syndrome of menopause | |
| WO2016063265A2 (pt) | Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos | |
| BR0212744A (pt) | Formulações de cisplatina de toxicidade reduzida e métodos para uso das mesmas | |
| US20220249512A1 (en) | Topical pharmaceutical compositions comprising diltiazem | |
| AR122320A1 (es) | Composiciones tópicas para el alivio del dolor | |
| CO6241114A2 (es) | Composicion farmaceutica que comprende la combinacion del agente antimicrobiano ciprofloxacino y el agente antioxidante acido ascorbico para el tratamiento de infecciones urinarias | |
| Ding et al. | Optimized Benzalkonium Chloride gel: A potential vaginal microbicides | |
| JPH11209291A (ja) | 痔疾治療剤 | |
| MX2021008353A (es) | Uso de nitazoxanida en el tratamiento de pacientes con covid-19. | |
| BR112021017238A2 (pt) | Redução de dosagem antibiótica em composições antibióticas/anti-inflamatórias combinadas para uso oftálmico | |
| AR044184A1 (es) | Metodo para el manejo terapeutico de la proliferacion extrauterina de tejido endometrial, dolor pelvico cronico y obstruccion de las trompas de falopio, las composiciones farmaceuticas utiles para la aplicacion de dicho metodo y el uso de un antagonista de lhrh para la preparacion de dichos medicame | |
| Khaled Hussein et al. | Hepatic hydatid disease: laparoscopic versus percutaneous treatment |